Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: RIOCIGUAT, . Treffer: 5
2022
Dachs, TM; Duca, F; Rettl, R; Binder-Rodriguez, C; Dalos, D; Ligios, LC; Kammerlander, A; Grunig, E; Pretsch, I; Steringer-Mascherbauer, R; Ablasser, K; Wargenau, M; Mascherbauer, J; Lang, IM; Hengstenberg, C; Badr-Eslam, R; Kastner, J; Bonderman, D
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial
EUR HEART J. 2022;
Doi: 10.1093/eurheartj/ehac389
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Hansmann, G; Christou, H; Koestenberger, M; Sallmon, H
Off-label use of PAH-targeted medications approved for adults and their financial coverage by health insurances are vital for children with pulmonary hypertension.
EUR J CLIN INVEST. 2021; 51(8): e13571
Doi: 10.1111/eci.13571
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hoeper, MM; Al-Hiti, H; Benza, RL; Chang, SA; Corris, PA; Gibbs, JSR; Grünig, E; Jansa, P; Klinger, JR; Langleben, D; McLaughlin, VV; Meyer, GMB; Ota-Arakaki, J; Peacock, AJ; Pulido, T; Rosenkranz, S; Vizza, CD; Vonk-Noordegraaf, A; White, RJ; Chang, M; Kleinjung, F; Meier, C; Paraschin, K; Ghofrani, HA; Simonneau, G; REPLACE investigators
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Lancet Respir Med. 2021;
Doi: 10.1016/S2213-2600(20)30532-4
Web of Science
PubMed
FullText
FullText_MUG
2013
Ghofrani, HA; D'Armini, AM; Grimminger, F; Hoeper, MM; Jansa, P; Kim, NH; Mayer, E; Simonneau, G; Wilkins, MR; Fritsch, A; Neuser, D; Weimann, G; Wang, C; CHEST-1 Study Group
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.
N Engl J Med. 2013; 369(4):319-329
Doi: 10.1056/NEJMoa1209657
Web of Science
PubMed
FullText
FullText_MUG
Ghofrani, HA; Galiè, N; Grimminger, F; Grünig, E; Humbert, M; Jing, ZC; Keogh, AM; Langleben, D; Kilama, MO; Fritsch, A; Neuser, D; Rubin, LJ; PATENT-1 Study Group
Riociguat for the treatment of pulmonary arterial hypertension.
N Engl J Med. 2013; 369(4):330-340
Doi: 10.1056/NEJMoa1209655
Web of Science
PubMed
FullText
FullText_MUG